Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD)

CUSIP: 76155X100

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+1,182,120
Put/Call ratio
238%
SEC-reported price per share
$45.35
Number of holders
252
Value change
+$69,484,732
Number of buys
141
Open additional details 1 more signal available
Number of sells
83
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
215,912,396

Security key

76155X100

Report period

Q3 2024

Institutions

252

Top holders

10

Ownership snapshot

Top reported holders of RVMD - Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Third Rock Ventures III, ...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5 13F Highest disclosed value: $558,021,707 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $558.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
Third Rock Ventures III, L.P. $137.81M
Third Rock Ventures II, L.P. $349K
VANGUARD GROUP INC $558.02M
WELLINGTON MANAGEMENT GROUP LLP $530.15M
BlackRock Finance, Inc. $520.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Third Rock Ventures III, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$137,811,510
5,104,130 shares
— 08 Jun 2022
Third Rock Ventures II, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$348,975
12,925 shares
— 03 Jun 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$558,021,707
14,378,297 shares
— 30 Jun 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$530,152,207
13,660,196 shares
— 30 Jun 2024
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$520,392,152
13,408,713 shares
— 30 Jun 2024
FARALLON CAPITAL MANAGEMENT, L.L.C.
13F
Company
13F
—
mixed-class rows
$378,704,589
9,877,777 shares
mixed-class rows
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
252
Shares
170,577,261
Rows available
252
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
221
Q3 2024 holders
252
Holder diff
31
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .